Brian Van Tine

61PUBLICATIONS
270CO-AUTHORS
Molecular targetsGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsSolid tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|May 26, 2026
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

|Jan 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

Robin L Jones, Roman Groisberg, Jean-Yves Blay

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Oct 13, 2025
Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma.

Miguel Esperança-Martins, Hugo Vasques, Manuel Sokolov Ravasqueira

|Jul 18, 2025
Trametinib Thwarts Activation of Survival Pathways Induced by Pro-ferroptotic Drug Conjugate ACXT-3102 Resulting in Enhanced Pancreatic Cancer Cell Death.

Kumar S Bishnupuri, Kenneth F Newcomer, Qingqing Gong

|Jul 03, 2025
Trametinib thwarts activation of survival pathways induced by pro-ferroptotic drug conjugate ACXT-3102 resulting in enhanced pancreatic cancer cell death.

Kumar S Bishnupuri, Kenneth F Newcomer, Qingqing Gong

Pageof 11

Frequent Collaborators

10 joint publications

Angela Hirbe

7 joint publications

Robin L Jones

6 joint publications

Richa Rathore

5 joint publications

Andrew J Wagner